Trupanion (NASDAQ:TRUP) Shares Gap Up – Should You Buy?

Trupanion, Inc. (NASDAQ:TRUP)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $46.52, but opened at $49.18. Trupanion shares last traded at $46.90, with a volume of 74,849 shares traded.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Piper Sandler upgraded Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price target on the stock in a research report on Thursday. Stifel Nicolaus upped their price target on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Finally, Northland Securities upped their price target on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $45.33.

Trupanion Trading Up 5.3 %

The firm has a market capitalization of $2.07 billion, a price-to-earnings ratio of -153.06, a price-to-earnings-growth ratio of 8.27 and a beta of 1.61. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a fifty day moving average price of $50.68 and a 200-day moving average price of $45.95.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. Trupanion’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same period in the prior year, the company posted ($0.10) earnings per share. On average, equities research analysts predict that Trupanion, Inc. will post -0.2 EPS for the current year.

Insider Buying and Selling at Trupanion

In related news, CFO Fawwad Qureshi sold 622 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the sale, the chief financial officer now owns 9,867 shares of the company’s stock, valued at $519,102.87. The trade was a 5.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Murray B. Low sold 2,000 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the completion of the sale, the director now directly owns 131,513 shares in the company, valued at approximately $6,926,789.71. The trade was a 1.50 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,597 shares of company stock worth $1,522,082 over the last 90 days. Insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Quest Partners LLC acquired a new position in Trupanion during the 3rd quarter worth about $37,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Trupanion during the 3rd quarter worth approximately $54,000. GAMMA Investing LLC grew its position in shares of Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after buying an additional 596 shares during the period. KBC Group NV bought a new stake in Trupanion in the fourth quarter valued at about $75,000. Finally, R Squared Ltd bought a new stake in Trupanion in the fourth quarter valued at about $79,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.